Investors bail out of MDS warrants
Article Abstract:
MDS Proteomics Inc., which is a subsidiary of MDS Inc., is losing institutional investors who are wary of its $82.5 million private placement of special warrants. MDS Proteomics, which is involved in drug development, has sold 3.3 special warrants in anticipation of an initial public offering.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
MDS IPO could fetch $200-million, analysts say
Article Abstract:
Toronto, Ont.-based MDS Inc. has announced that its proteomics division will launch an initial public offering that is expected to raise between $100 million and $200 million. MDS Proteomics Inc. will launch the IPO in the US and Canada.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
CryoCath sails IPO in stormy seas
Article Abstract:
Montreal, Ont.-based CryoCath Technologies Inc. has launched an initial public offering, raising about $40 million. CryoCath, which is a biotechnology company, is facing financial volatility in the biosciences sector.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Pilots union turf war brews. Air Canada warns workers. Air Canada cuts 3,500 jobs
- Abstracts: Rogers to pay out dividend. CHUM, Rogers still in specialty TV deadlock. Rogers Communications shares fall 11%
- Abstracts: Tobin's exit raises hopes about Voisey's. Inco strikes supply deal in Australia
- Abstracts: Steel makers sound dumping alarm. Stelco loss reflects steel industry woes. CITT throws out galvanized-steel dumping case
- Abstracts: CGI grows-but at what cost? QSC investigating Jitec trades